Similar Articles
1711 Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study
1712 Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition
1713 Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma
1714 Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
1715 Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma
1716 Early steroid withdrawal after liver transplantation for hepatocellular carcinoma
1717 Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma
1718 18F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer
1719 Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells
1720 Hepatocellular carcinoma masquerading as a bleeding gastric ulcer: A case report and a review of the surgical management
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA